Private Equity

PE Fund Investments

MO Alts acquires 60% stake in API maker Megafine Pharma for Rs.460-Cr

Business Standard   Megafine Pharma  

Motilal Oswal Alternates Investment Advisors (MO Alts) has acquired over 60% stake in Mumbai-based, export-focused active pharmaceutical ingredients (API) manufacturer Megafine Pharma .The investment, totalling INR 460 crore, will go to existing shareholders and will be used to bolster Megafine’s research and development (R&D) capabilities while expanding its manufacturing infrastructure. The company plans to increase its production capacity by 50% over the next two years.Megafine currently operates two USFDA-approved manufacturing facilities located in Nashik, Maharashtra, and Vapi, Gujarat, and specialises in niche, high-margin APIs, primarily used in chronic disease management, such as cardiovascular and physiotherapy drugs.